Innate Pharma to hold its annual general meeting of shareholders on May 21, 2026

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of shareholders (“AGM”) at 10:30 a.m. CEST on May 21, 2026, at its headquarters, 117 avenue de Luminy, 13009 Marseille.  

The notice of meeting for this AGM was published on April 13, 2026 in the French Bulletin des annonces légales obligatoires (BALO). It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM.  

Documents and information relating to the AGM will be made available to shareholders in compliance with current regulations on the Investors section of the Company's website.

****

The AGM will also be broadcast live and accessible at the following link:  

Innate Pharma 2026 Annual General Meeting

A guided tour of the Company's laboratories will be organized on the same day at 9:15 a.m. CEST for shareholders. Shareholders can register for the tour via the following link: registration form.

****

Further information regarding the AGM:

Only shareholders who have registered their shares in an account at least five trading business days prior to the date of the AGM, i.e. May 14, 2026, at 00:00 (Paris time), will be entitled to attend the General Meeting.

Shareholders holding “au porteur” (bearer) shares will need to obtain an “attestation de participation” (certificate of shareholding) from their brokers. This “attestation de participation” must be attached to the voting or proxy form.

Written questions from shareholders must be received no later than four business days prior to the AGM, i.e. May 15, 2026, at the following address: investors@innate-pharma.fr.

Shareholders can also obtain the documents and information relating to the AGM (as described in Article R. 225-83 of the French Commercial Code) by sending a request by e-mail to investors@innate-pharma.fr.